MarketCapTrends
CNMD
CONMED Corporation (CNMD)
NYSE · Healthcare

CONMED Corporation Shareholder Equity 2009–2025

CONMED Corporation annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • CONMED Corporation shareholder equity for the quarter ending December 31, 2025 were 1.03B, a 7.31% increase year-over-year.
  • CONMED Corporation shareholder equity for 2025 were 1.03B, a 7.31% increase from 2024.
  • CONMED Corporation shareholder equity for 2024 were 962.7M, a 15.40% increase from 2023.
  • CONMED Corporation shareholder equity for 2023 were 834.2M, a 11.89% increase from 2022.
  • CONMED Corporation shareholder equity for 2022 were 745.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
CONMED Corporation Annual Shareholder Equity (Millions of US $)
2025$1,033
2024$963
2023$834
2022$746
2021$785
2020$709
2019$710
2018$662
2017$631
2016$581
2015$585
2014$581
2013$606
2012$607
2011$573
CONMED Corporation Quarterly Shareholder Equity (Millions of US $)
2025-12-31$1,033
2024-12-31$963
2023-12-31$834
2022-12-31$746
2021-12-31$785
2020-12-31$709
2019-12-31$710
2018-12-31$662
2017-12-31$631
2016-12-31$581
2015-12-31$585
2014-12-31$581
2013-12-31$606
2012-12-31$607
2011-12-31$573
2010-12-31$587

CONMED Corporation Shareholder Equity — FAQ

CONMED Corporation (CNMD) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CNMD's shareholder equity history?

The chart and table above show CONMED Corporation's shareholder equity by year and by quarter, including the growth rate.